Modulation of fluid pumping in isolated bovine mesenteric lymphatics by a thromboxane/endoperoxide analogue.
A thromboxane/endoperoxide analogue (compound U46619) is known to stimulate phasic and tonic contractions in quiescent bovine lymphatic vessels and enhance contractile activity in spontaneously active vessels. In order to determine how these effects relate to changes in fluid propulsion by the lymphatics, we have assessed the effects of U46619 on the ability of isolated bovine mesenteric lymphatics to pump fluid in vitro. Bovine lymphatic segments (up to 8 cm in length with a minimum of 4 valves) were cannulated at both ends and fluid input provided from a reservoir. Flow through the vessels was regulated by intraluminal pressures. On average, changes in transmural pressures up to 8 cm H2O resulted in enhanced pumping; pressures above this level depressed flow. The dominant effect of U46619 (added to the reservoir) was to depress pumping; 10(-7) and 10(-9)M decreased flow at all transmural pressures tested; 10(-8)M had a dual effect, slightly inhibiting flow at low transmural pressures and enhancing flow at higher pressures. These results suggest that thromboxane may stimulate or inhibit lymphatic pumping depending on the concentration of the agent and the transmural pressure applied to the vessel. These effects may relate to its ability to induce variable changes in luminal diameter and frequency and force of contractions.
Elias
R M
RM
Department of Pathology, University of Toronto, Ontario, Canada.
Johnston
M G
MG
D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D000818:Animals; D002417:Cattle; D008208:Lymphatic System / Q000187:drug effects*; D011312:Pressure; D011450:Prostaglandin Endoperoxides, Synthetic / Q000494:pharmacology*
D011450:Prostaglandin Endoperoxides, Synthetic; D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid